terminologie-lahn
type: CodeSystem
node role: treeRoot
id:
  v: terminologie-lahn
meta:
  version id:
    v: 4
  last updated:
    v: 2025-11-18T17:19:42.810+01:00
  profile:
    v: http://hl7.org/fhir/StructureDefinition/shareablecodesystem|4.0.1
    l: http://hl7.org/fhir/StructureDefinition/shareablecodesystem
text:
  status:
    v: generated
  div:
    v: La liste des actes innovants hors nomenclature (LAHN) a été mise en place par la direction générale de l’offre de soins (DGOS) en 2024, dans le cadre du développement de l’innovation en santé. Elle est la fusion du RIHN et de la Liste Complémentaire (LC). L’objectif est de soutenir l’innovation et de la dynamiser par une prise en charge et une évaluation rapide des actes innovants. La LAHN contient une liste d’actes innovants (biologie et anatomocytopathologie) pris en charge à titre transitoire moyennant un recueil de données pour leur évaluation.
url:
  v: https://smt.esante.gouv.fr/terminologie-lahn
  l: terminologie-lahn
identifier:
  use:
    v: usual
  system:
    v: urn:ietf:rfc:3986
    l: 3986
  value:
    v: urn:oid:1.2.250.1.213.2.79
identifier:
  use:
    v: secondary
  system:
    v: https://smt.esante.gouv.fr/
    l: smt.esante.gouv.fr
  value:
    v: terminologie-lahn
version:
  v: 2025 v1.0
name:
  v: LAHN
title:
  v: Liste des Actes Inovants Hors Nomenclature
status:
  v: active
experimental:
  v: false
date:
  v: 2026-01-26T15:30:52+00:00
publisher:
  v: Agence du numérique en santé
description:
  v: La liste des actes innovants hors nomenclature (LAHN) a été mise en place par la direction générale de l’offre de soins (DGOS) en 2024, dans le cadre du développement de l’innovation en santé. Elle est la fusion du RIHN et de la Liste Complémentaire (LC). L’objectif est de soutenir l’innovation et de la dynamiser par une prise en charge et une évaluation rapide des actes innovants. La LAHN contient une liste d’actes innovants (biologie et anatomocytopathologie) pris en charge à titre transitoire moyennant un recueil de données pour leur évaluation.
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: FRA
copyright:
  v: [LOv2](https://github.com/etalab/licence-ouverte/blob/master/LO.md)
value set:
  v: https://smt.esante.gouv.fr/terminologie-lahn
  l: https://smt.esante.gouv.fr/terminologie-lahn
content:
  v: complete
count:
  v: 766
filter:
  code:
    v: root
  operator:
    v: =
  value:
    v: True or false.
filter:
  code:
    v: deprecated
  operator:
    v: =
  value:
    v: True or false.
filter:
  code:
    v: imported
  operator:
    v: =
  value:
    v: True or false
property:
  code:
    v: created
  uri:
    v: http://purl.org/dc/terms/created
    l: created
  type:
    v: dateTime
property:
  code:
    v: modified
  uri:
    v: http://purl.org/dc/terms/modified
    l: modified
  type:
    v: dateTime
property:
  code:
    v: type
  uri:
    v: http://purl.org/dc/elements/1.1/type
    l: type
  description:
    v: Type fonctionnel d'un concept
  type:
    v: string
property:
  code:
    v: note
  uri:
    v: http://www.w3.org/2004/02/skos/core#note
    l: note
  type:
    v: string
property:
  code:
    v: deprecated
  uri:
    v: http://www.w3.org/2002/07/owl#deprecated
    l: deprecated
  type:
    v: boolean
property:
  code:
    v: parent
  uri:
    v: http://hl7.org/fhir/concept-properties#parent
    l: parent
  description:
    v: Codes des parents du concept courant
  type:
    v: code
property:
  code:
    v: child
  uri:
    v: http://hl7.org/fhir/concept-properties#child
    l: child
  description:
    v: Codes des enfants du concept courant
  type:
    v: code
property:
  code:
    v: imported
  description:
    v: Indicates if the concept is imported from another code system.
  type:
    v: boolean
property:
  code:
    v: root
  description:
    v: Indicates if this concept is a root concept (i.e. Thing is equivalent or a direct parent).
  type:
    v: boolean
concept:
  code:
    v: K202
  display:
    v: Alpha 2 macroglobuline (alpha 2 macroglo) (dosage) (liquides biologiques autres que sang)
  property:
    code:
      v: parent
    value: Code
      v: 11-01
  property:
    code:
      v: created
    value: DateTime
      v: 2018-01-01T00:00:00+00:00
  property:
    code:
      v: modified
    value: DateTime
      v: 2025-01-01T00:00:00+00:00
  property:
    code:
      v: type
    value: String
      v: code
  property:
    code:
      v: note
    value: String
      v: En attente d'une modification potentielle du libellé de l'acte NABM [1805] prenant en compte les autres liquides biologiques que le sang.
concept:
  code:
    v: G195
  display:
    v: Test d'activation des basophiles par cytométrie en flux
  property:
    code:
      v: parent
    value: Code

Code
v: 07-01

code:
  v: created
value: DateTime
  v: 2018-01-01T00:00:00+00:00

code:
  v: modified
value: DateTime
  v: 2025-01-01T00:00:00+00:00

code:
  v: type
value: String
  v: code

code:
  v: note
value: String
  v: Par dilution d'un d'allergène testé. Examen utile dans le cas ou la recherche d'IgE spécifiques n'est pas contributive. Standardisation nationale des modalités opératoires en cours. Acte à encadrer pour le contrôle de la prescription et des étapes analytiques et post-analytique

code:
  v: G062
display:
  v: Dosage de mica soluble
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K117
display:
  v: Facteur chimioattractant MCP-1
property:
  code:
    v: parent
  value: Code
    v: 11-05
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: P058
display:
  v: Etude par immuno-empreinte d'une ou plusieurs protéines (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Indication: protéine(s) déjà connue(s) pour être en lien avec la pathologie héréditaire recherchée.

code:
  v: C017
display:
  v: Conservation annuelle de tissu germinaux (ovaire et testicule prépubère)
property:
  code:
    v: parent
  value: Code
    v: 03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2020-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation par an et par patient(e). Remplace Cryoconservation de tissu germinaux (ovaire et testicule prépubère)
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: I047
display:
  v: Métanéphrines plasmatiques libres (LC/MS/MS)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé

code:
  v: J003
display:
  v: Phosphatases alcalines (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0514] prenant en compte les autres liquides biologiques que le sang.

code:
  v: N518
display:
  v: Transcrit de fusion, fibrosarcome infantile (1 transcrit)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: N409
display:
  v: Identification d’anomalies structurelles des syndromes lymphoprolifératifs et lymphomes non hodgkiniens par locus (forfait 2 à 5 anomalies de structure (gènes de fusion)) (par ex BCL1-IgH ou BCL2-IgH (forfaitisé avec les SLP et LNH)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2019-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [N409], [N410] et [N413]
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: J027
display:
  v: Catalase tissulaire
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: K116
display:
  v: Isoprostanes
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: G085
display:
  v: Test d’exploration fonctionnelle de l’apoptose des lymphocytes T
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Mesure de l'apoptose par annexine v (par couple annexine v + Ac ou IP) sur culture de lymphocytes T activés

code:
  v: P057
display:
  v: Analyse quantitative et qualitative des glycosaminoglycanes (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Inclut la quantification des glycosaminoglycanes totaux et analyse qualitative des 4 espèces majoritaires des mucopolysaccharides

code:
  v: G194
display:
  v: Herpesviridae (HSV, CMV, VZV) : Charge immunitaire
property:
  code:
    v: parent
  value: Code
    v: 07-07
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: I048
display:
  v: Progestérone (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0334] prenant en compte les autres liquides biologiques que le sang.

code:
  v: I024
display:
  v: CBG ( Cortisol Binding Protein) (sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé

code:
  v: L229
display:
  v: Activité de la Protéine de Transfert des Esters de Cholestérol (CETP)
property:
  code:
    v: parent
  value: Code
    v: 10-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: N519
display:
  v: Amplification MDM2/CDK4
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: J004
display:
  v: Phosphatases acides (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: C100
display:
  v: Suivi continu des embryons "système time-lapse"
property:
  code:
    v: parent
  value: Code
    v: 03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: J028
display:
  v: Cholinestérase ou pseudocholinesterases
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K119
display:
  v: Mélanine (recherche)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: P056
display:
  v: Profil des oligosaccharides (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Par technique séparative

code:
  v: I049
display:
  v: 17OH Progestérone (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [1135] prenant en compte les autres liquides biologiques que le sang.

code:
  v: I025
display:
  v: FSH (liquide biologique autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0473] prenant en compte les autres liquides biologiques que le sang.

code:
  v: I001
display:
  v: HCG ou béta HCG (recherche ou dosage dans un liquide biologique autre que le sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente de la fusion potentielle des actes NABM [7401] et [7402] et d'une modification potentielle du libellé de l'acte résultant prenant en compte les autres liquides biologiques que le sang.
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: N516
display:
  v: Transcrit de fusion, tumeur desmoplastique à cellules rondes (1 transcrit)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: N407
display:
  v: Recherche ou quantification du transcrit de fusion BCR-ABL1 par RT-PCR
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: J029
display:
  v: Cholinestérases érythrocytaires
property:
  code:
    v: parent
  value: Code
    v: 10-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: A033
display:
  v: Examen cytopathologique ou histopathologiques en microscopie électronique
property:
  code:
    v: parent
  value: Code
    v: 01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [A030], [A031], [A032], [A033].

code:
  v: K203
display:
  v: Cathepsine et Visfatine
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: P055
display:
  v: Neurotransmetteurs (LCR)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: I026
display:
  v: LH (liquide biologique autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0472] prenant en compte les autres liquides biologiques que le sang.

code:
  v: N408
display:
  v: Recherche et/ou quantification au diagnotic par locus
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Hors BCR-ABL [1035 de la NABM]. Par exemple : CCND1, EVI1, TLX1/3, CRLF, DEK-CAN, STAT3, FLT3…

code:
  v: L207
display:
  v: Activité bilirubine UDP glucuronosyltransférase sur tissu hépatique
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: N517
display:
  v: Transcrit de fusion, sarcome fibromyxoide de bas grade
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: J006
display:
  v: Alanine aminotransférase (ALAT, TGP) (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0516] prenant en compte les autres liquides biologiques que le sang.
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: G191
display:
  v: Dosage des IgG anti-antigène capsulaire du pneumocoque (sérologie pneumococcique) (réponse vaccinale)
property:
  code:
    v: parent
  value: Code
    v: 07-05
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: E107
display:
  v: Prothrombine résiduelle du sérum
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Examen simple de dépistage d'une anomalie des phospholipides plaquettaires (syndrome de Scott)

code:
  v: I003
display:
  v: Hormone Anti-Mullërienne (AMH)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Très prescrit
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: N934
display:
  v: Test de résistance aux antiviraux par séquençage des gènes porteurs de mutations de résistance [<3000 bases]
property:
  code:
    v: parent
  value: Code
    v: 14-2-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Inclus : contrôle pré-analyse, extraction, quelle que soit la méthode, amplification du gène (partiel ou complet) par PCR simple ou nichée, contrôle rapide de PCR sur gel d'agarose, réaction de séquence, analyse des données, interprétation et rendu des résultats. Une cotation par séquence

code:
  v: C012
display:
  v: IMSI (choix des spermatozoïdes à injecter dans l'ovocyte suite à leur observation à très fort grossissement)
property:
  code:
    v: parent
  value: Code
    v: 03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Observation longue car cette technique est indiquée en cas de spermatozoïdes présentant un très fort pourcentage d'anomalies morphologiques. Permet la sélection à fort grossissement (X 6000) des spermatozoïdes sans anomalies morphologiques à injecter dans l'ovocyte. Une seule cotation qui s'ajoute à l'acte NABM ICSI [0061].

code:
  v: G081
display:
  v: PN : Expression des molécules d'adhérence CD11b, CD18, CD62L
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Par molécule. Acte devant être encadré pour sa prescription et les étapes pré et post analytiques

code:
  v: G190
display:
  v: Dosage des IgG anti-haemophilus (réponse vaccinale)
property:
  code:
    v: parent
  value: Code
    v: 07-05
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: E108
display:
  v: Résistance à la Protéine C activée (RPCa)
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Intérêt de dépister en cas de pathologie acquise un risque thrombotique

code:
  v: N935
display:
  v: Test de résistance aux antiviraux par séquençage des gènes porteurs de mutations de résistance [>3000 bases]
property:
  code:
    v: parent
  value: Code
    v: 14-2-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Inclus : contrôle pré-analyse, extraction, quelle que soit la méthode, amplification du gène (partiel ou complet) par PCR simple ou nichée, contrôle rapide de PCR sur gel d'agarose, réaction de séquence, analyse des données, interprétation et rendu des résultats. Une cotation par séquence

code:
  v: C011
display:
  v: Prélèvement de globules polaires ou blastomères en vue de diagnostic préconceptionnel (DPC) ou de diagnostic préimplantatoire (DPI)
property:
  code:
    v: parent
  value: Code
    v: 03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: J008
display:
  v: Aspartate aminotransférase (ASAT, TGO) (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0517] prenant en compte les autres liquides biologiques que le sang.

code:
  v: D100
display:
  v: Etude de la qualité du noyau du spermatozoïde
property:
  code:
    v: parent
  value: Code
    v: 04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: L094
display:
  v: Clairance au vert d'indocyanine
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Réserve hépatique ou évaluation post-opératoire

code:
  v: B034
display:
  v: Hybridation sur puce à ADN (sans les vérifications)
property:
  code:
    v: parent
  value: Code
    v: 02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: P059
display:
  v: Exploration par BN-PAGE de la chaine respiratoire mitochondriale (tout tissus)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: I006
display:
  v: IGFBP 1 (Iinsulin-like growth factor binding protein 1) (sécrétions vaginales)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé

code:
  v: E106
display:
  v: Protéine S, recherche d'un auto-Ac
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Utilité diagnostique démontrée en biologie médicale. Impact sur la prise en charge thérapeutique

code:
  v: C013
display:
  v: Test pré-IMSI
property:
  code:
    v: parent
  value: Code
    v: 03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Ce test correspond à évaluer la possibilité de trouver des spermatozoïdes" utilisables" pour une IMSI ultérieure

code:
  v: 11
display:
  v: Protéines - Marqueurs tumoraux - Vitamines
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 11-01
property:
  code:
    v: child
  value: Code
    v: 11-06
property:
  code:
    v: child
  value: Code
    v: 11-07
property:
  code:
    v: child
  value: Code
    v: 11-02
property:
  code:
    v: child
  value: Code
    v: 11-04
property:
  code:
    v: child
  value: Code
    v: 11-03
property:
  code:
    v: child
  value: Code
    v: 11-05

code:
  v: I087
display:
  v: Résistine
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: K157
display:
  v: IgD (dosage en nephelemetrie) (sang)
property:
  code:
    v: parent
  value: Code
    v: 11-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: [K157] et [K158] : même mesure mais méthodes différentes. Dosage également en turbidimétrie ; interprétation biologique nécessitant une expertise, à associer avec exploration de la mévalonate kinase

code:
  v: M009
display:
  v: Métal ou autre élément : dosage par spectrométrie d'émission atomique avec ionisation par plasma induit (icp-oes)
property:
  code:
    v: parent
  value: Code
    v: 13-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une cotation par métal ou autre élément dosé

code:
  v: K048
display:
  v: RBP (retinol binding protein) (dosage) (liquides biologiquesautres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [1818] prenant en compte les autres liquides biologiques que le sang.

code:
  v: M118
display:
  v: Génotypage du cytochrome P450 2D6 dans le cadre d’une prescription d’eluglistat ou de tamoxifène
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G240
display:
  v: sérodiagnostic de staphylocoque par cytométrie en flux
property:
  code:
    v: parent
  value: Code
    v: 07-05
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Détection des infections ostéo-articulaires

code:
  v: 10-04
display:
  v: Enzymologie lipidique
property:
  code:
    v: parent
  value: Code
    v: 10
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: L229
property:
  code:
    v: child
  value: Code
    v: J016
property:
  code:
    v: child
  value: Code
    v: J085
property:
  code:
    v: child
  value: Code
    v: J052

code:
  v: G155
display:
  v: Auto-Ac anti-NMO (neuro-myélite optique) (par IFI)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G022
display:
  v: Ac anti-cytoplasme : identification des anti-ARNt-synthétases et autres anti-Ag cytoplasmiques (autres que JO1)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G131
display:
  v: Herpes 8 IgG ELISA
property:
  code:
    v: parent
  value: Code
    v: 07-07
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G179
display:
  v: Etude du chimérisme (sur sang total ou moelle)
property:
  code:
    v: parent
  value: Code
    v: 07-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: A réaliser au sein de laboratoires accrédités par l'European Federation for Imunogenetics (EFI)

code:
  v: L137
display:
  v: Acide lactique (liquides biologiques autres que sang, ponction)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [L137], [L142] et [L183]. En attente d'une modification potentielle du libellé de l'acte NABM [0530] prenant en compte les autres liquides biologiques que le sang.

code:
  v: F041
display:
  v: Culture Trichomonas
property:
  code:
    v: parent
  value: Code
    v: 06-05
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: La culture des prélèvements augmente la sensibilité du diagnostic

code:
  v: N534
display:
  v: Mutation IDH1/2
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Prise en charge des gliomes

code:
  v: L028
display:
  v: Acides gras libres T0 à T16 (sang)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: N510
display:
  v: Transcrit de fusion, chondrosarcome myxoïde (3 transcrits)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: 10-03
display:
  v: Enzymologie érythrocytaire
property:
  code:
    v: parent
  value: Code
    v: 10
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: J044
property:
  code:
    v: child
  value: Code
    v: L046
property:
  code:
    v: child
  value: Code
    v: J064
property:
  code:
    v: child
  value: Code
    v: L045
property:
  code:
    v: child
  value: Code
    v: J091
property:
  code:
    v: child
  value: Code
    v: J026
property:
  code:
    v: child
  value: Code
    v: J103
property:
  code:
    v: child
  value: Code
    v: J097
property:
  code:
    v: child
  value: Code
    v: J029

code:
  v: L113
display:
  v: Urée (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [L113] et [L181]. En attente d'une modification potentielle du libellé de l'acte NABM [0591] prenant en compte les autres liquides biologiques que le sang.

code:
  v: J043
display:
  v: Glutathion péroxydase
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: P050
display:
  v: Chromatographie des acides aminés (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Au moins les 22 acides aminés nutritionnels

code:
  v: I088
display:
  v: Peptide YY (PYY, Peptide Tyrosine Tyrosine, Pancreatic Peptide YY)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: K047
display:
  v: IgM (liquides biologiques autres que le sang, ponctions)
property:
  code:
    v: parent
  value: Code
    v: 11-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [1816] prenant en compte les autres liquides biologiques que le sang.

code:
  v: M119
display:
  v: Dosage de l’activité de la dihydropyridine deshydrogenase par une méthode chromatographique pour ajustement d’un traitement par fluoropyrimidines (ex : 5-fluorouracile)
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2020-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: G154
display:
  v: Auto-Ac anti-21-hydroxylase (par RIA)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K156
display:
  v: Dépistage des déficits d'interaction du facteur H aux surfaces
property:
  code:
    v: parent
  value: Code
    v: 11-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examen de 1ère intention dans certaines pathologies (MAT) ; réalisation technique et interprétation biologique nécessitant une expertise
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: N317
display:
  v: Mise au point d'une PCR quantitative à façon pour vérification d'une anomalie détectée en microarray
property:
  code:
    v: parent
  value: Code
    v: 14-3-1
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: (comprend le design des oligonucléotides, la commande et l'analyse en PCRq des parents et du propositus)

code:
  v: L027
display:
  v: Acide gras à très longue chaine (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: De C22 à C26 minimum

code:
  v: E086
display:
  v: Fragment 1.2 de la prothrombine
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Marqueur d'activation de la coagulation (activation de la prothrombine)

code:
  v: N535
display:
  v: Mutation BRAF (hors mutation V600)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: N511
display:
  v: Transcrit de fusion, rhabdomyosarcome (2 transcrits)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: L003
display:
  v: Cuivre (liquide biologique autres que sang)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [L003] et [L130] en attente d'une modification potentielle du libellé de l'acte NABM [0547] prenant en compte les autres liquides biologiques que le sang.

code:
  v: J020
display:
  v: Acétylcholinestérase
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: 10
display:
  v: Enzymologie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 10-02
property:
  code:
    v: child
  value: Code
    v: 10-01
property:
  code:
    v: child
  value: Code
    v: 10-03
property:
  code:
    v: child
  value: Code
    v: 10-04
property:
  code:
    v: child
  value: Code
    v: J083

code:
  v: J044
display:
  v: Glutathion réductase érythrocytaire
property:
  code:
    v: parent
  value: Code
    v: 10-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K159
display:
  v: Ferritine (liquides biologiques autres que sang, ponctions)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [1213] prenant en compte les autres liquides biologiques que le sang.
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: 13
display:
  v: Médicaments - Toxiques
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 13-02
property:
  code:
    v: child
  value: Code
    v: 13-01

code:
  v: K026
display:
  v: C3 nephritic factor (Ac anti C3 convertase alterne) par technique hémolytique
property:
  code:
    v: parent
  value: Code
    v: 11-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examens de première intention ; réalisation technique et interprétation biologique nécessitant une expertise

code:
  v: K135
display:
  v: Immunoblot anti-C1 inhibiteur
property:
  code:
    v: parent
  value: Code
    v: 11-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examen de seconde intention dans le cadre d'un déficit fonctionnel de C1 inhibiteur ; encadrement de la prescription et nécessité d'une expertise technique
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: I041
display:
  v: GHRH (sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé

code:
  v: M007
display:
  v: Métaux et autres éléments : dosage multiélémentaire par spectrométrie de masse avec ionisation par plasma induit (icp-ms)
property:
  code:
    v: parent
  value: Code
    v: 13-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Avec plafonnement à 5 éléments par prélèvement

code:
  v: M116
display:
  v: Screening toxicologique comprenant au moins 200 molécules par une méthode de chromatographie avec identification de l'ensemble des molécules
property:
  code:
    v: parent
  value: Code
    v: 13-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Non cumulable avec acte [M117]

code:
  v: G068
display:
  v: PN : étude de l'amorçage de l'explosion oxydative
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G044
display:
  v: Ac anti-Ag onco-neuronaux
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G153
display:
  v: Auto-Ac anti-récepteur sensible au calcium (par immunotransfert)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K111
display:
  v: Ac récepteur de la TSH bloquant
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: I089
display:
  v: Ghréline (sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: F063
display:
  v: Identification de Légionella par agglutination
property:
  code:
    v: parent
  value: Code
    v: 06-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente de l'intégration potentielle au sein de l'acte NABM [5292] de l'identification de Légionella par agglutination

code:
  v: L139
display:
  v: Protéine Tau et ses isoformes (phosphorylation (phospho-Tau), exon-spécifique, clivage..) en dosage individuel (tout liquide biologique)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Quelle que soit la technique (ELISA, spectrométrie de masse…) par dosage d'un isoforme

code:
  v: N314
display:
  v: Forfait Tests fonctionnels ex vivo imposant de recourir à la mutagénèse dirigée ou à un clonage en minigène
property:
  code:
    v: parent
  value: Code
    v: 14-3-1
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Ce forfait concerne la confirmation du caractère délétère d'une mutation identifiée par l'analyse de l'ADN génomique lorsque le gène s'exprime dans un tissu non accessible.

code:
  v: N532
display:
  v: Méthylation MGMT
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Marqueur prédictif dans les glioblastomes

code:
  v: J045
display:
  v: Glutathion S transférase (GST) alpha
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: K049
display:
  v: Transferrine ou sidérophylline (liquides biologiques autres que le sang)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [1819] prenant en compte les autres liquides biologiques que le sang.

code:
  v: 12
display:
  v: Biochimie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: L188
property:
  code:
    v: child
  value: Code
    v: L124
property:
  code:
    v: child
  value: Code
    v: L170
property:
  code:
    v: child
  value: Code
    v: L137
property:
  code:
    v: child
  value: Code
    v: L049
property:
  code:
    v: child
  value: Code
    v: L017
property:
  code:
    v: child
  value: Code
    v: L100
property:
  code:
    v: child
  value: Code
    v: L044
property:
  code:
    v: child
  value: Code
    v: L177
property:
  code:
    v: child
  value: Code
    v: L113
property:
  code:
    v: child
  value: Code
    v: L172
property:
  code:
    v: child
  value: Code
    v: L140
property:
  code:
    v: child
  value: Code
    v: L084
property:
  code:
    v: child
  value: Code
    v: L139
property:
  code:
    v: child
  value: Code
    v: L107
property:
  code:
    v: child
  value: Code
    v: L121
property:
  code:
    v: child
  value: Code
    v: L001
property:
  code:
    v: child
  value: Code
    v: L235
property:
  code:
    v: child
  value: Code
    v: L147
property:
  code:
    v: child
  value: Code
    v: L161
property:
  code:
    v: child
  value: Code
    v: L059
property:
  code:
    v: child
  value: Code
    v: L041
property:
  code:
    v: child
  value: Code
    v: L128
property:
  code:
    v: child
  value: Code
    v: L110
property:
  code:
    v: child
  value: Code
    v: L008
property:
  code:
    v: child
  value: Code
    v: L054
property:
  code:
    v: child
  value: Code
    v: L022
property:
  code:
    v: child
  value: Code
    v: L187
property:
  code:
    v: child
  value: Code
    v: L109
property:
  code:
    v: child
  value: Code
    v: L003
property:
  code:
    v: child
  value: Code
    v: L094
property:
  code:
    v: child
  value: Code
    v: L043
property:
  code:
    v: child
  value: Code
    v: L218
property:
  code:
    v: child
  value: Code
    v: L011
property:
  code:
    v: child
  value: Code
    v: L176
property:
  code:
    v: child
  value: Code
    v: L125
property:
  code:
    v: child
  value: Code
    v: L083
property:
  code:
    v: child
  value: Code

Code
v: L178

code:
  v: child
value: Code
  v: L072

code:
  v: child
value: Code
  v: L173

code:
  v: child
value: Code
  v: L085

code:
  v: child
value: Code
  v: L053

code:
  v: child
value: Code
  v: L021

code:
  v: child
value: Code
  v: L034

code:
  v: child
value: Code
  v: L002

code:
  v: child
value: Code
  v: L135

code:
  v: child
value: Code
  v: L236

code:
  v: child
value: Code
  v: L028

code:
  v: child
value: Code
  v: L217

code:
  v: child
value: Code
  v: L010

code:
  v: child
value: Code
  v: L111

code:
  v: child
value: Code
  v: L087

code:
  v: child
value: Code
  v: L009

code:
  v: child
value: Code
  v: L020

code:
  v: child
value: Code
  v: L097

code:
  v: child
value: Code
  v: L099

code:
  v: child
value: Code
  v: L029

code:
  v: child
value: Code
  v: L190

code:
  v: child
value: Code
  v: L064

code:
  v: child
value: Code
  v: L133

code:
  v: child
value: Code
  v: L146

code:
  v: I042
display:
  v: Biotine B8 (sang)
property:
  code:
    v: parent
  value: Code
    v: 11-06
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K025
display:
  v: AP50 ou AH50 par réaction d’hémolyse
property:
  code:
    v: parent
  value: Code
    v: 11-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une cotation par dosage. Examen de première intention

code:
  v: K158
display:
  v: IgD (dosage en ELISA) (sang)
property:
  code:
    v: parent
  value: Code
    v: 11-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: [K157] et [K158] : même mesure mais méthodes différentes. Dosage également en turbidimétrie ; interprétation biologique nécessitant une expertise, à associer avec exploration de la mévalonate kinase

code:
  v: M117
display:
  v: Screening toxicologique comprenant au moins 200 molécules par au moins 2 méthodes de chromatographie complémentaires avec identification de l'ensemble des molécules
property:
  code:
    v: parent
  value: Code
    v: 13-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Non cumulable avec acte [M116]

code:
  v: G152
display:
  v: Auto-Ac anti-ZnT8 en radioligand assay
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: M008
display:
  v: Métal ou autre élément : dosage isolé par spectrométrie de masse avec ionisation par plasma induit (icp-ms)
property:
  code:
    v: parent
  value: Code
    v: 13-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G067
display:
  v: PN : mouvement spontané et chimiotactisme des PN
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Acte devant être encadré pour sa prescription et les étapes pré et post analytiques

code:
  v: G043
display:
  v: M. de l'intestin : recherche des Ac anti-saccharomyces cerevisiae (ASCA) d'isotype IgG par ELISA
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G176
display:
  v: Typage d'un locus HLA de classe I ou de classe II en biologie moléculaire, résolution haute
property:
  code:
    v: parent
  value: Code
    v: 07-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [G176] et [G177]. A réaliser selon standards EFI

code:
  v: K110
display:
  v: Ac récepteur de la TSH stimulant
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: J046
display:
  v: Glutathion S transférase pi
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: L114
display:
  v: Protéines totales (liquides biologiques hors sang)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [2258] prenant en compte les autres liquides biologiques que le sang.

code:
  v: N315
display:
  v: Forfait Test fonctionnels ex vivo à partir de matériel issu du patient (ARN ou protéine)
property:
  code:
    v: parent
  value: Code
    v: 14-3-1
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Ce forfait concerne la confirmation du caractère délétère d'une mutation identifiée par analyse de l'ADN génomique en étudiant les ARN ou les protéines du patient.

code:
  v: L138
display:
  v: TRAP (Total Peroxyl Radical Tracking Antioxydant) (sang)
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: L029
display:
  v: Acides gras non estérifiés
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2019-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: E084
display:
  v: Facteur XIII, Ag
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. A réaliser seulement si acte [0173]] diminué. A réserver à centre de référence ou centre expert.

code:
  v: N400
display:
  v: Recherche de clonalité B par locus
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [N400], [N401], [N402] et [N403]

code:
  v: N533
display:
  v: Méthylation MLH-1
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Indique le caractère sporadique de cancers avec instabilité des microsatellites

code:
  v: K137
display:
  v: Mannan Binding Lectin (MBL) (dosage fonctionnel)
property:
  code:
    v: parent
  value: Code
    v: 11-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examen de 2nde ou 3ième intention ; nécessité d'une expertise technique
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: K113
display:
  v: Ac anti-T3 (Sérum)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G042
display:
  v: M. de l'intestin : recherche des Ac anti-saccharomyces cerevisiae (ASCA) d'isotype IgA par ELISA
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G151
display:
  v: Auto-Ac anti-IA2 en radioligand assay
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: 15
display:
  v: Diagnostic prénatal
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre

code:
  v: G199
display:
  v: Ac anti-Annexine V IgG
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: L008
display:
  v: Iode (sang)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Pas d'EEQ. Technique actuelle ICPMS .Intérêt dans interventions thyroïde.

code:
  v: N514
display:
  v: Transcrit de fusion, sarcome à cellules claires (2 transcrits)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: A120
display:
  v: Enzymologie sur coupe > 3 enzymes
property:
  code:
    v: parent
  value: Code
    v: 01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une cotation par lame

code:
  v: P054
display:
  v: Points redox
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Comprenant les acides lactiques, pyruvique, 3-hydroxy-butirique et acéto-acétique

code:
  v: E081
display:
  v: Facteur VIII, Ag
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Recommandations du CRMH, en cours de rédaction, préconiseront le dosage antigènique en complément de la caractérisation phénotypique basée sur les mesures d’activité, afin de reconnaître les hémophiles CRM.

code:
  v: 14
display:
  v: Tests d'amplification génique et d'hybridation moléculaire (diagnostic prénatal exclu)
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 14-2
property:
  code:
    v: child
  value: Code
    v: 14-1
property:
  code:
    v: child
  value: Code
    v: 14-3

code:
  v: K003
display:
  v: Protéines membranaires érythrocytaires (électrophorèses)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G041
display:
  v: Ac antirécepteur insuline
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G174
display:
  v: Typage d'un locus HLA de classe I ou de classe II en biologie moléculaire, résolution basse ou intermédiaire
property:
  code:
    v: parent
  value: Code
    v: 07-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [G174] et [G175]. A réaliser selon standards EFI

code:
  v: B100
display:
  v: Dépistage non invasif des anomalies chromosomiques par analyse de l'ADN fœtal circulant
property:
  code:
    v: parent
  value: Code
    v: 02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Indications : hors indications des actes 4084, 4085, 4086, 4087 et 4088 de la NABM et selon les recommandations de la HAS

code:
  v: A122
display:
  v: Analyse protéomique basée sur la spectrométrie de masse en tandem après microdissection laser
property:
  code:
    v: parent
  value: Code
    v: 01
property:
  code:
    v: created
  value: DateTime
    v: 2020-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Typage des amyloses

code:
  v: G150
display:
  v: Auto-Ac anti-GAD en radioligand assay
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G089
display:
  v: Test de prolifération en thymidine tritiée sur PBMC
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Pour une stimulation. 10 stimulations maximum. Acte devant être encadré pour sa prescription et les étapes pré et post analytiques

code:
  v: G065
display:
  v: Marquage cellulaire quelqu'il soit en cytométrie en flux (par Ac)
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Cotation totale maximale limitée à 24 Ac, y compris CD3, CD4, CD8 et CD45. Ne pas comptabiliser les contrôles isotypiques et les Ac de fenêtrage inclus dans le code NABM [1122]. Acte devant être encadré pour sa prescription et les étapes pré et post analytiques

code:
  v: G198
display:
  v: MAI nso : Ac anti phospholipides (autres que ceux codifiés en 1460 et G023 et G024) IgG et IgM
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Par isotype

code:
  v: N515
display:
  v: Transcrit de fusion (RET/PTC1, RET/PTC3)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: F062
display:
  v: Mycobactéries : identification par immunochromatographie
property:
  code:
    v: parent
  value: Code
    v: 06-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: A121
display:
  v: Autopsie adulte (> 15 ans et 3 mois) : moelle épinière
property:
  code:
    v: parent
  value: Code
    v: 01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examen macroscopique et histologique après bloc paraffine de la moelle épinière

code:
  v: B101
display:
  v: Clonage des points de cassures par séquençage haut débit
property:
  code:
    v: parent
  value: Code
    v: 02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Hors exome et génome entier, pour séquence < 500 kb

code:
  v: E082
display:
  v: Facteur XI, Ag
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Permet une caractérisation complète du diagnostic de déficit en facteur XI

code:
  v: P053
display:
  v: Chromatographie des porphyrines (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Profil de 6 porphyrines minimum

code:
  v: K115
display:
  v: Ac anti-TSH (Sérum)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: 17
display:
  v: Microbiologie médicale par pathologie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre

code:
  v: K139
display:
  v: Activité de la Carboxypeptidase N
property:
  code:
    v: parent
  value: Code
    v: 11-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Analyse ultra spécialisée

code:
  v: G040
display:
  v: Auto-Ac anti-transglutaminase IgG en radioligand assay
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G088
display:
  v: Test de cytotoxicité: pour le test de base
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Par cible. Acte devant être encadré pour sa prescription et les étapes pré et post analytiques

code:
  v: N318
display:
  v: Recherche de réarrangements génomiques ciblés par Multiplex Ligation-dependent Probe Amplification (MLPA).
property:
  code:
    v: parent
  value: Code
    v: 14-3
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Concerne un nombre limité de maladies héréditaires pour lesquelles la recherche de réarragements récurrents reste nécessaire au diagnostic (ex: Amyotrophie spinale). Permet également l'évaluation des gains ou pertes alleliques dans les leucémies ou lymphomes.

code:
  v: N536
display:
  v: Réarrangement du gène ROS-1
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: L'acte n'est pas à coder au RAHN lorsqu'il s'agit d'un acte dans des indications de cancers bronchiques

code:
  v: N512
display:
  v: Transcrit de fusion, liposarcome myxoide (3 transcrits)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: P052
display:
  v: Profil des acylcarnitines (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: De C2 à C18 minimum

code:
  v: I022
display:
  v: Adiponectine
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: K138
display:
  v: Activité de l'Aminopeptidase P
property:
  code:
    v: parent
  value: Code
    v: 11-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Analyse ultra spécialisée. Dosage sur cinétique longue, substrat FRET Fluorescence (ou Förster Resonance Energy Transfert) permet d'étudier des interactions entre deux molécules, les évènements de proximité dans les système biologique.

code:
  v: K114
display:
  v: Ac anti-T4 (Sérum)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G063
display:
  v: Evaluation du contenu en myélopéroxydase des Polynucléaires Neutrophiles (PN)
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: 16
display:
  v: Diagnostic biologique des maladies héréditaire
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 16-01
property:
  code:
    v: child
  value: Code
    v: 16-02

code:
  v: I046
display:
  v: Glucagon-like-peptide 1 (GLP-1)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: J002
display:
  v: Phosphatases alcalines isoenzymes (électrophorèse) (sang)
property:
  code:
    v: parent
  value: Code
    v: 10-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé

code:
  v: L009
display:
  v: Manganèse (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [L009] et [L078]. Intérêt dans certaines neuropathies.

code:
  v: J026
display:
  v: Catalase érythrocytaire
property:
  code:
    v: parent
  value: Code
    v: 10-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: N404
display:
  v: Recherche de clonalité T par locus
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [N404], [N405] et [N406]

code:
  v: N537
display:
  v: Signature d'expression génique dans le cancer du sein
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Indications : selon les indications de la HAS

code:
  v: N513
display:
  v: Transcrit de fusion, synovialosarcome (2 transcrits)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Identification d'anomalies spécifiques dans les sarcomes

code:
  v: P051
display:
  v: Chromatographie des acides organiques (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 16-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: 07
display:
  v: Immunologie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 07-02
property:
  code:
    v: child
  value: Code
    v: 07-04
property:
  code:
    v: child
  value: Code
    v: 07-07
property:
  code:
    v: child
  value: Code
    v: 07-03
property:
  code:
    v: child
  value: Code
    v: 07-06
property:
  code:
    v: child
  value: Code
    v: 07-05
property:
  code:
    v: child
  value: Code
    v: 07-01

code:
  v: G200
display:
  v: Ac anti-fibrillarine
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K185
display:
  v: Ostéoprotégérine sérique
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: M013
display:
  v: Autre médicament ou toxique : dosage par électrochimie (électrodes spécifiques)
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une cotation par médicament ou toxique dosé

code:
  v: K161
display:
  v: Ac anti-Thyroglobuline (liquide de ponction)
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [1484] prenant en compte les autres liquides biologiques que le sang.

code:
  v: G115
display:
  v: Toxoplasmose: Recherche d'autres marqueurs de toxoplasmose évolutive pour datation et évaluation du risque si sérologie de dépistage évoquant une infection évolutive: IgM
property:
  code:
    v: parent
  value: Code
    v: 07-06
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2020-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examen réservé à des laboratoires agréés ou spécialisés. ISAGA ou 2ème ELISA. Valeur des IgA et IgM pour différencier une toxoplasmose évolutive d'une séquelle sérologique (selon les recommandations du CNR de la toxoplasmose):
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: G224
display:
  v: Typage d'un locus HLA de classe I ou de classe II en biologie moléculaire, résolution allélique
property:
  code:
    v: parent
  value: Code
    v: 07-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Selon standards EFI

code:
  v: V008
display:
  v: PCR classique ou temps réel quantitative multiplex pour < 10 couples d'amorces (ADN/ARN) - Indications évaluées par la HAS
property:
  code:
    v: parent
  value: Code
    v: 14-2
property:
  code:
    v: created
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Les indications suivantes ont été évaluées par la HAS permettant une exemption à la décote : https://www.has-sante.fr/upload/docs/application/pdf/2024-11/rapport_taan_igi_vd.pdf https://www.has-sante.fr/upload/docs/application/pdf/2024-12/rapport_taan_irb_vd.pdf https://www.has-sante.fr/upload/docs/application/pdf/2025-01/rapport_taan_inm_vd.pdf

code:
  v: E154
display:
  v: Activité anti thrombine ou anti Xa des médicaments (hors héparine ou dérivés)
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une cotation par nouveau antithrombotique. Dosage + courbe pour nouveaux antithrombotiques. test indispensable permettant d'évaluer la concentration du médicament afin d'évaluer le risque hémorragique pour les AOD et la zone thérapeutique pour les anti-thrombines administrés par voie IV

code:
  v: E130
display:
  v: Propeptide facteur Willebrand
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Voir recommandations du Centre de référence Maladie de Willebrand : examen de 2nde intention pour la caractérisation d'une VWD

code:
  v: I091
display:
  v: Hormone de croissance (somatotropine) (GH) (liquides biologiques autres que sang)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé. En attente d'une modification potentielle du libellé de l'acte NABM [7423] prenant en compte les autres liquides biologiques que le sang.

code:
  v: L056
display:
  v: Diènes conjugués (sang)
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: N453
display:
  v: Forfait séquençage haut débit (NGS) > 20 kb et < 100 kb
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Selon indications fixées par l'INCa et la DGOS Lorsqu'il s'agit d'un acte qui concerne un test de détection des mutations génétiques [Test compagnon], l'acte n'est pas à coder au RAHN car il est inscrit à la CCAM et à la NABM : https://www.legifrance.gouv.fr/download/pdf?id=e1zu17CprDOqj9lE78rLBxw7vDZFNnoUYrgSjWmeUG4=

code:
  v: F025
display:
  v: Ag soluble Pneumocoque par Test immunochromatographique
property:
  code:
    v: parent
  value: Code
    v: 06-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: 06
display:
  v: Microbiologie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 06-05
property:
  code:
    v: child
  value: Code
    v: 06-03
property:
  code:
    v: child
  value: Code
    v: 06-01
property:
  code:
    v: child
  value: Code
    v: 06-02
property:
  code:
    v: child
  value: Code
    v: 06-04
property:
  code:
    v: child
  value: Code
    v: 06-06

code:
  v: K184
display:
  v: Collagène de type IV
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Marqueur de fibrose hépatique

code:
  v: K160
display:
  v: Des-gamma-carboxy prothrombine (DCP) ou PIVKA
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K051
display:
  v: Dosages sériques des chaines légères libres kappa et lambda (sérum)
property:
  code:
    v: parent
  value: Code
    v: 11-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des ancien code [K051] et [K052]. Examen de 1ere intention dans certaines indications pour le dosage sérique. Réalisation technique et interprétation biologique nécessitant une expertise

code:
  v: K099
display:
  v: Ferritine glycosylée
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G114
display:
  v: Toxoplasmose: Recherche d'autres marqueurs de toxoplasmose évolutive pour datation et évaluation du risque si sérologie de dépistage évoquant une infection évolutive: IgG
property:
  code:
    v: parent
  value: Code
    v: 07-06
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2020-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examen réservé à des laboratoires agréés ou spécialisés. IFI ou 2ème ELISA ou TS dilué. 2ème technique nécessaire en cas de résultats 1ère technique limite ou non quantifiable ou si discordance entre les 2 premières techniques IgG. Importance de confirmer la spécificité des faible taux d'IgG dans toute suspiscion de toxoplasmose évolutive
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: V007
display:
  v: PCR classique ou temps réel qualitative multiplex pour < 10 couples d'amorces (ADN/ARN) - Indications évaluées par la HAS
property:
  code:
    v: parent
  value: Code
    v: 14-2
property:
  code:
    v: created
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Les indications suivantes ont été évaluées par la HAS permettant une exemption à la décote : https://www.has-sante.fr/upload/docs/application/pdf/2024-11/rapport_taan_igi_vd.pdf https://www.has-sante.fr/upload/docs/application/pdf/2024-12/rapport_taan_irb_vd.pdf https://www.has-sante.fr/upload/docs/application/pdf/2025-01/rapport_taan_inm_vd.pdf

code:
  v: G139
display:
  v: AC neutralisant anti IFN-bêta
property:
  code:
    v: parent
  value: Code
    v: 07-04
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: E046
display:
  v: Willebrand, fixation au collagène (liaison VWF-collagène)
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Voir recommandations du Centre de référence Maladie de Willebrand : examen de 2nde intention pour la caractérisation d'une VWD

code:
  v: E155
display:
  v: Typage d’un variant de l’hémoglobine (étude phénotypique) hormis isofloculation et citrate agar
property:
  code:
    v: parent
  value: Code
    v: 05-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Combinaison de 7 techniques alternatives : électrophorèse sur acétate de cellulose pH9, urée pH9, urée pH6, urée/triton, HPLC sur birad® Variant I, HPLC sur gel de silice en phase normale et phase inverse, électrophorèse capillaire de chaine dénaturante et électrophorèse capillaire non dénaturante.

code:
  v: E131
display:
  v: Willebrand : liaison VWF-GPIb
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Voir recommandations du Centre de référence Maladie de Willebrand : examen de 2nde intention pour la caractérisation d'une VWD

code:
  v: L055
display:
  v: Statut antioxydant total (TAS) (sang)
property:
  code:
    v: parent
  value: Code
    v: 10-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: L188
display:
  v: Acide urique (liquides biologiques autres que sang, ponctions)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [L188] et [L193]. En attente d'une modification potentielle du libellé de l'acte NABM [0532] prenant en compte les autres liquides biologiques que le sang.

code:
  v: N454
display:
  v: Forfait séquençage haut débit (NGS) > 100 kb et < 500 kb
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Selon indications fixées par l'INCa et la DGOS Lorsqu'il s'agit d'un acte qui concerne un test de détection des mutations génétiques [Test compagnon], l'acte n'est pas à coder au RAHN car il est inscrit à la CCAM et à la NABM : https://www.legifrance.gouv.fr/download/pdf?id=e1zu17CprDOqj9lE78rLBxw7vDZFNnoUYrgSjWmeUG4=

code:
  v: L140
display:
  v: Peptide Amyloïde béta et ses isoformes (1-42, 1-40, 1-38, tronqué, PyroGlu, précurseur...) en dosage individuel (tout liquide biologique)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Quelle que soit la technique (ELISA, spectrométrie de masse…) par dosage d'un isoforme

code:
  v: 11-02
display:
  v: Complément (exploration du complément et marqueurs associés)
property:
  code:
    v: parent
  value: Code
    v: 11
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: K032
property:
  code:
    v: child
  value: Code
    v: K197
property:
  code:
    v: child
  value: Code
    v: K026
property:
  code:
    v: child
  value: Code
    v: K034
property:
  code:
    v: child
  value: Code
    v: K199
property:
  code:
    v: child
  value: Code
    v: K135
property:
  code:
    v: child
  value: Code
    v: K194
property:
  code:
    v: child
  value: Code
    v: K156
property:
  code:
    v: child
  value: Code
    v: K036
property:
  code:
    v: child
  value: Code
    v: K137
property:
  code:
    v: child
  value: Code
    v: K196
property:
  code:
    v: child
  value: Code
    v: K044
property:
  code:
    v: child
  value: Code
    v: K025
property:
  code:
    v: child
  value: Code
    v: K038
property:
  code:
    v: child
  value: Code
    v: K033
property:
  code:
    v: child
  value: Code
    v: K198
property:
  code:
    v: child
  value: Code
    v: K035

code:
  v: I093
display:
  v: Insulin-like Growth Factor-II (IGF-II) ou Somatomédine A haut poids moléculaire (par western-blot)
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation

code:
  v: 09
display:
  v: Hormonologie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: I048
property:
  code:
    v: child
  value: Code
    v: I094
property:
  code:
    v: child
  value: Code
    v: I088
property:
  code:
    v: child
  value: Code
    v: I056
property:
  code:
    v: child
  value: Code
    v: I024
property:
  code:
    v: child
  value: Code
    v: I083
property:
  code:
    v: child
  value: Code
    v: I051
property:
  code:
    v: child
  value: Code
    v: I101
property:
  code:
    v: child
  value: Code
    v: I091
property:
  code:
    v: child
  value: Code
    v: I058
property:
  code:
    v: child
  value: Code
    v: I026
property:
  code:
    v: child
  value: Code
    v: I039
property:
  code:
    v: child
  value: Code
    v: I034
property:
  code:
    v: child
  value: Code
    v: K015
property:
  code:
    v: child
  value: Code
    v: I079
property:
  code:
    v: child
  value: Code
    v: I047
property:
  code:
    v: child
  value: Code
    v: I093
property:
  code:
    v: child
  value: Code
    v: I061
property:
  code:
    v: child
  value: Code
    v: I010
property:
  code:
    v: child
  value: Code
    v: I087
property:
  code:
    v: child
  value: Code
    v: I050
property:
  code:
    v: child
  value: Code
    v: I049
property:
  code:
    v: child
  value: Code
    v: I017
property:
  code:
    v: child
  value: Code
    v: I100
property:
  code:
    v: child
  value: Code
    v: I089
property:
  code:
    v: child
  value: Code
    v: I025
property:
  code:
    v: child
  value: Code
    v: I084
property:
  code:
    v: child
  value: Code
    v: I006
property:
  code:
    v: child
  value: Code
    v: I052
property:
  code:
    v: child
  value: Code
    v: I001
property:
  code:
    v: child
  value: Code
    v: I102
property:
  code:
    v: child
  value: Code
    v: I046
property:
  code:
    v: child
  value: Code
    v: I060
property:
  code:
    v: child
  value: Code
    v: I041
property:
  code:
    v: child
  value: Code
    v: I054
property:
  code:
    v: child
  value: Code
    v: I022
property:
  code:
    v: child
  value: Code
    v: I003

code:
  v: K163
display:
  v: Polyamines (spermine, spermidine, putrescine) par polyamine
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: G028
display:
  v: Ac anti- titine
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: M120
display:
  v: Dosage d’un anti-inflammatoire par une méthode chromatographique dans un liquide biologique
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K054
display:
  v: Dosage d'une cytokine ou d'un récepteur de cytokines par ELISA (toute cytokine, tout récepteur)
property:
  code:
    v: parent
  value: Code
    v: 11-05
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Même mesure , méthode analytique différente dont le choix dépend de la nature de l'échantilon, le nombre de tests d'un série. Un grand nombre de cytokines peuvent être dosées dans des situations cliniques très variées. Les données analytiques et l'efficacité et l'utilité cliniques sont très variables selon les cytokines et le contexte clinique. Quelques indications précises sont identifiées (IL-10 dans le LCR ou l'humeur vitrée pour le diagnostic de lymphome, IL-6 dans le LCR et SEP. D'autres doivent être évaluées.

code:
  v: K187
display:
  v: Vitamine E (érythrocytaire)
property:
  code:
    v: parent
  value: Code
    v: 11-06
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Spécialisé

code:
  v: E067
display:
  v: Antithrombine, activité progressive
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fait partie du diagnostic de déficit en antithrombine.

code:
  v: E043
display:
  v: Willebrand, activité inhibitrice (anti facteur Willebrand)
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Ce test a son intérêt dans le syndrome de VWD acquis et la recherche d'alloAc chez les VWD type 3 mais les performances analytiques sont à valider.

code:
  v: E152
display:
  v: Monomères de fibrine technique quantitative sur automate
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une seule cotation. Technique automatisée dans le cadre de l'accréditation

code:
  v: L034
display:
  v: Apolipoprotéine E (phénotype)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: N451
display:
  v: Quantification d'une cible d'oncogénétique somatique lors du diagnostic ou du suivi d'une leucémie ou d'un lymphome (ou Maladie Résiduelle)
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Sont définies pour chaque hémopathie maligne l'identification des cibles moléculaires et leur nombre

code:
  v: J097
display:
  v: Enolase érythrocytaire
property:
  code:
    v: parent
  value: Code
    v: 10-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2019-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: L010
display:
  v: Sélénium (liquides biologiques)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Fusion des actes [L010] et [L079]. Intérêt dans déficits immunitaires, hémodialysés, sujets fragilisés, maladies infectieuses, cardiopathies, intoxications alimentaires,…..

code:
  v: 11-01
display:
  v: Protéines
property:
  code:
    v: parent
  value: Code
    v: 11
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: K048
property:
  code:
    v: child
  value: Code
    v: K306
property:
  code:
    v: child
  value: Code
    v: L050
property:
  code:
    v: child
  value: Code
    v: K176
property:
  code:
    v: child
  value: Code
    v: K301
property:
  code:
    v: child
  value: Code
    v: E042
property:
  code:
    v: child
  value: Code
    v: K184
property:
  code:
    v: child
  value: Code
    v: K096
property:
  code:
    v: child
  value: Code
    v: K077
property:
  code:
    v: child
  value: Code
    v: K202
property:
  code:
    v: child
  value: Code
    v: K160
property:
  code:
    v: child
  value: Code
    v: K303
property:
  code:
    v: child
  value: Code
    v: K173
property:
  code:
    v: child
  value: Code
    v: K021
property:
  code:
    v: child
  value: Code
    v: K186
property:
  code:
    v: child
  value: Code
    v: K154
property:
  code:
    v: child
  value: Code
    v: K098
property:
  code:
    v: child
  value: Code
    v: K162
property:
  code:
    v: child
  value: Code
    v: K130
property:
  code:
    v: child
  value: Code
    v: K305
property:
  code:
    v: child
  value: Code
    v: K300
property:
  code:
    v: child
  value: Code
    v: K049
property:
  code:
    v: child
  value: Code
    v: K017
property:
  code:
    v: child
  value: Code
    v: K164
property:
  code:
    v: child
  value: Code
    v: K012
property:
  code:
    v: child
  value: Code
    v: K302
property:
  code:
    v: child
  value: Code
    v: L114
property:
  code:
    v: child
  value: Code
    v: K185
property:
  code:
    v: child
  value: Code
    v: K180
property:
  code:
    v: child
  value: Code
    v: K203
property:
  code:
    v: child
  value: Code
    v: K193
property:
  code:
    v: child
  value: Code
    v: K304
property:
  code:
    v: child
  value: Code
    v: K109
property:
  code:
    v: child
  value: Code
    v: K099
property:
  code:
    v: child
  value: Code
    v: K003
property:
  code:
    v: child
  value: Code
    v: K016
property:
  code:
    v: child
  value: Code
    v: K163
property:
  code:
    v: child
  value: Code

Code
v: K152

code:
  v: child
value: Code
  v: K119

code:
  v: child
value: Code
  v: K159

code:
  v: child
value: Code
  v: J104

code:
  v: child
value: Code
  v: K020

code:
  v: H008
display:
  v: Recherche non orientée par ME
property:
  code:
    v: parent
  value: Code
    v: 08-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: I094
display:
  v: Analyse des métabolites urinaires du cortisol en HPLC MS/MS comprend : cortisol, cortisone, THF, allo THF, THE, alpha cortol, bêta cortol, alpha cortolone et bêta cortolone,
property:
  code:
    v: parent
  value: Code
    v: 09
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Etape enzymatique préalable incluse

code:
  v: K162
display:
  v: Protéine Amyloïde A (SAA)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: 08
display:
  v: Virologie
property:
  code:
    v: parent
  value: Code
    v: LAHN
property:
  code:
    v: type
  value: String
    v: Chapitre
property:
  code:
    v: child
  value: Code
    v: 08-01
property:
  code:
    v: child
  value: Code
    v: 08-02

code:
  v: N149
display:
  v: Herpès virus humain 6: typage (détermination de variant A ou B)
property:
  code:
    v: parent
  value: Code
    v: 14-2-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Validation d'un examen fondé sur une double PCR spécifique qualitative en temps réel

code:
  v: M012
display:
  v: Autre médicament ou toxique : dosage par colorimétrie
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Une cotation par médicament ou toxique dosé

code:
  v: G027
display:
  v: Ac anti-MuSK
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: M121
display:
  v: Dosage de deux médicaments immunosuppresseurs prélevés simultanément (ciclosporine, acide mycophénolique, tacrolimus, sirolimus, évérolimus,…) par une méthode chromatographique dans le sang
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K186
display:
  v: Copeptine
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Cet acte est à coupler avec une troponine haute sensibilité (diagnostic d'exclusion) et un ECG ne montrant pas un infarctus du myocarde.

code:
  v: K077
display:
  v: Peptide collagène III (p-III-p)
property:
  code:
    v: parent
  value: Code
    v: 11-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G136
display:
  v: HIV différenciation M1/2-0
property:
  code:
    v: parent
  value: Code
    v: 07-07
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: V009
display:
  v: PCR classique ou temps réel qualitative multiplex pour ≥ 10 couples d'amorces (ADN/ARN) - Indications évaluées par la HAS
property:
  code:
    v: parent
  value: Code
    v: 14-2
property:
  code:
    v: created
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Les indications suivantes ont été évaluées par la HAS permettant une exemption à la décote : https://www.has-sante.fr/upload/docs/application/pdf/2024-11/rapport_taan_igi_vd.pdf https://www.has-sante.fr/upload/docs/application/pdf/2024-12/rapport_taan_irb_vd.pdf https://www.has-sante.fr/upload/docs/application/pdf/2025-01/rapport_taan_inm_vd.pdf

code:
  v: E044
display:
  v: Willebrand, analyse des multimères
property:
  code:
    v: parent
  value: Code
    v: 05-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Analyse des multimères (méthode complexe). Une seule cotation. Voir recommandations du Centre de référence Maladie de Willebrand : examen de 2nde intention pour la caractérisation d'une VWD

code:
  v: H007
display:
  v: Antivirogramme herpèsvirus
property:
  code:
    v: parent
  value: Code
    v: 08-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Par antiviral testé vis-à-vis d'un virus de la famille des Herpesviridae

code:
  v: N452
display:
  v: Forfait séquençage haut débit (NGS) < 20 kb
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Selon indications fixées par l'INCa et la DGOS Lorsqu'il s'agit d'un acte qui concerne un test de détection des mutations génétiques [Test compagnon], l'acte n'est pas à coder au RAHN car il est inscrit à la CCAM et à la NABM : https://www.legifrance.gouv.fr/download/pdf?id=e1zu17CprDOqj9lE78rLBxw7vDZFNnoUYrgSjWmeUG4=

code:
  v: 11-04
display:
  v: Immunoglobulines
property:
  code:
    v: parent
  value: Code
    v: 11
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: K157
property:
  code:
    v: child
  value: Code
    v: K083
property:
  code:
    v: child
  value: Code
    v: K051
property:
  code:
    v: child
  value: Code
    v: K045
property:
  code:
    v: child
  value: Code
    v: K146
property:
  code:
    v: child
  value: Code
    v: K085
property:
  code:
    v: child
  value: Code
    v: K047
property:
  code:
    v: child
  value: Code
    v: K148
property:
  code:
    v: child
  value: Code
    v: K050
property:
  code:
    v: child
  value: Code
    v: K158
property:
  code:
    v: child
  value: Code
    v: K046
property:
  code:
    v: child
  value: Code
    v: K147
property:
  code:
    v: child
  value: Code
    v: K086
property:
  code:
    v: child
  value: Code
    v: K081

code:
  v: G111
display:
  v: Trichinose : SD de confirmation par une technique IE (western blot)
property:
  code:
    v: parent
  value: Code
    v: 07-06
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: La technique d'immunoempreinte est plus sensible et plus spécifique :
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: M102
display:
  v: Génotypage de la dihydropyrimidine deshydrogénase (DPYD) pour ajustement de la dose d'un traitement par fluoropyrimidines (ex : 5-fluorouracile)
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2019-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: G244
display:
  v: Ac anti-pompe à protons
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: K141
display:
  v: Activité kininogénase spontanée du plasma
property:
  code:
    v: parent
  value: Code
    v: 11-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Analyse ultra spécialisée

code:
  v: G026
display:
  v: Ac anti-IgA
property:
  code:
    v: parent
  value: Code
    v: 07-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: V004
display:
  v: Forfait séquençage haut débit (NGS) < 20 kb (cas index) - Indications évaluées par la HAS
property:
  code:
    v: parent
  value: Code
    v: 14-3-1
property:
  code:
    v: created
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Les indications suivantes ont été évaluées par la HAS permettant une exemption à la décote : https://www.has-sante.fr/upload/docs/application/pdf/2025-02/rapport_shd_cardiomyopathies.pdf

code:
  v: K032
display:
  v: Dosage fonctionnel de C1 inhibiteur
property:
  code:
    v: parent
  value: Code
    v: 11-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Examens de première intention ; réalisation technique et interprétation biologique nécessitant une expertise

code:
  v: N457
display:
  v: Forfait mutationnel syndromes lymphoprolifératifs et lymphomes non-Hodgkiniens
property:
  code:
    v: parent
  value: Code
    v: 14-3-2
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Mutations à impact diagnostique et/ou théranostique des syndromes lymphoprolifératifs et lymphomes non hodgkiniens (forfait 2 à 5) : MYD88 L265P, BRAF V600E, STAT3 exons 20 et 21, TP53 exons 4 à 9, NOTCH1 exon 34. Par cible

code:
  v: L121
display:
  v: Phosphore minéral (dyalisat)
property:
  code:
    v: parent
  value: Code
    v: 12
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [0563] prenant en compte les autres liquides biologiques que le sang.

code:
  v: 11-05
display:
  v: Cytokines
property:
  code:
    v: parent
  value: Code
    v: 11
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: K055
property:
  code:
    v: child
  value: Code
    v: K151
property:
  code:
    v: child
  value: Code
    v: K054
property:
  code:
    v: child
  value: Code
    v: K117

code:
  v: H006
display:
  v: VIH antivirogramme
property:
  code:
    v: parent
  value: Code
    v: 08-02
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: deprecated
  value: Boolean
    v: true

code:
  v: 11-03
display:
  v: Dosages impliqués dans l'exploration d'un angioedème
property:
  code:
    v: parent
  value: Code
    v: 11
property:
  code:
    v: type
  value: String
    v: Sous-chapitre
property:
  code:
    v: child
  value: Code
    v: K138
property:
  code:
    v: child
  value: Code
    v: K141
property:
  code:
    v: child
  value: Code
    v: K140
property:
  code:
    v: child
  value: Code
    v: K139
property:
  code:
    v: child
  value: Code
    v: K142

code:
  v: K140
display:
  v: Activité de la Dipeptidylpeptidase IV
property:
  code:
    v: parent
  value: Code
    v: 11-03
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: Analyse ultra spécialisée. Dosage sur cinétique longue, substrat FRET

code:
  v: M103
display:
  v: Génotypage de la thiopurine-s-méthyl-transférase (TPMT) pour ajustement de la dose d'un traitement comprenant un médicament thiopurinique
property:
  code:
    v: parent
  value: Code
    v: 13-01
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code

code:
  v: G110
display:
  v: Paludisme : recherche Ag solubles par une technique immunochromatographique (tests de diagnostic rapide).
property:
  code:
    v: parent
  value: Code
    v: 07-06
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2025-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: A faire si frottis et goutte épaisse négatifs. Cf. conférence de consensus sur la prise en charge du paludisme de la société de pathologie. La recherche des Ag plasmodiaux dans le sang circulant est un outil indispensable au diagnostic de paludismeen France de part sa sensibilité, sa spécificité et sa rapidité/facilité de réalisation au regard d'une pathologie potentiellement léthale:

code:
  v: K188
display:
  v: Ag prostatique spécifique (PSA) (dosage) (liquides biologiques autres que sang)
property:
  code:
    v: parent
  value: Code
    v: 11-07
property:
  code:
    v: created
  value: DateTime
    v: 2018-01-01T00:00:00+00:00
property:
  code:
    v: modified
  value: DateTime
    v: 2022-01-01T00:00:00+00:00
property:
  code:
    v: type
  value: String
    v: code
property:
  code:
    v: note
  value: String
    v: En attente d'une modification potentielle du libellé de l'acte NABM [7318] prenant en compte les autres liquides biologiques que le sang.